With dissertation titled “Relationship between Genotype and Phenotype with Z-endoxifene levels in Breast Cancer Subjects treated with Tamoxifene”; with promoter Prof. Dr. dr. Rianto Setiabudy, Sp.FK, a Permanent Professor in Pharmacology – the Faculty of Medicine, University of Indonesia.
The Session was held on Wednesday, January 16th
, 2019 in IMERI Tower Edukasi, 3rd
floor of Auditorium 1 Faculty of Medicine University of Indonesia, Jl. Salemba Raya No.06, Central Jakarta.
the session was led by Prof. Dr. dr. Ari Fahrial syam, Sp.PD-KGEH.,MMB, as Dean of Faculty of Medicine, University of Indonesia; Co-promoter 1 Dr. dr. Sonar Soni P, Sp.B(K)-Onk, M.Epid., M.A.R.S as Head Professor of Oncology Surgery - FK Trisakti University; Co-promoter 2 Prof. Dr. dr. Adi Hidayat, MS, a Permanen Professor of Public Health Science FK Trisakti University.
Head of Examiner Team Dr. dr. Suhendro, Sp.PD-KPTI Head Professor of Internal Disease University of Indonesia with examiner team as follows: Dr. Melva Lousia Apt., MBiomed, Lector in Pharmacology - FK University of Indonesia, Dr. dr. Denni Joko Purwanto, Sp.B(K)-Onk, a Main Primary Coach of Oncology Surgery of Dharmais Cancer Hospital; Dr. dra. Riska Andalucia, Apt. Pharm, a Main Coach of National Agency of Drugs and Food Control (BPOM).
The session was attended by Chairman of Senate of Trisakti University Prof. Dr. dr. Pusparini, Sp.PK; Leaders of the Faculty of Medicine Trisakti University, Dean of the Faculty of Medicine Usakti Dr. dr. Raditya Wratsangka, SpOG (K), Vice Dean I of FK Dr. dr. Elly Herwana, M.Biomed, Vice Dean III of FK dr. Tubagus Ferdi Fadillah, Sp.A, M.Kes and former Dean dr. Hj. Suriptiastuti, DAP&E, MS.
The result of Open Session decided Promovenda graduated with Cumlaude achievement and GPA 3,93 with short study period, e.i two and half years or 5 semesters.
Hopefully with the increasing number of doctors, it will further strengthen and improve accreditation and quality of the Faculty of Medicine – Trisakti University.
(Source : IG@usakti_official)